Does Highmark Blue Cross Blue Shield Cover ADHD Treatment in Delaware? A 2026 Guide

Last updated: July 22, 2026

If you have Highmark Blue Cross Blue Shield in Delaware and are seeking ADHD treatment, understanding your pharmacy and medical benefits is an important first step. Highmark BCBS Delaware (Highmark BCBSD Inc.) is the state’s largest Blue Cross Blue Shield insurer, serving both commercial and Medicare Advantage members. Coverage for ADHD medications and services may vary by plan, and prior authorization requirements apply to many ADHD drugs.

Key Facts: Highmark BCBS Delaware. ADHD Coverage

• Insurer: Highmark BCBSD Inc. d/b/a Highmark Blue Cross Blue Shield
• Pharmacy Benefit Manager (PBM): Express Scripts (ESI)
• State parity law: Del. Code Ann. tit. 18, § 3343 (MHPAEA alignment)
• DE EPCS requirement: Schedule II stimulants require electronic prescribing (EPCS REQUIRED). Non-stimulant ADHD medications are non-scheduled. EPCS entirely inapplicable.
• Generic stimulants: Typically Tier 1. 2, often no prior authorization required
• Brand stimulants: Tier 3. 4, prior authorization + step therapy required
• Member services: 1-800-241-5704
• Express Scripts: 1-800-792-9558
• DE Insurance Commissioner: 1-302-674-7300

Klarity Health connects Delaware residents with licensed, ADHD-specialized providers who accept many Highmark Blue Cross Blue Shield plans. Over 2,000 providers are in our network. Check if your Highmark plan may cover ADHD treatment through Klarity.

About Highmark Blue Cross Blue Shield Delaware

Highmark BCBSD Inc. is the Blue Cross Blue Shield licensee for Delaware, operating as Highmark Blue Cross Blue Shield. The company offers individual and family plans, employer-sponsored group plans, and Medicare Advantage plans for Delaware residents. On the pharmacy side, Highmark BCBS Delaware partners with Express Scripts (ESI) to administer prescription drug benefits for most commercial and Medicare Advantage members.

Unlike Cigna/ESI plans, which adopted a blanket prior authorization policy for all stimulants in May 2026, Highmark’s use of ESI does not automatically mean the same clinical policies apply. Highmark maintains its own clinical coverage policies, and generic stimulant ADHD medications are typically covered at Tier 1. 2 without mandatory prior authorization for most commercial plans.

Delaware Mental Health Parity: Del. Code Ann. tit. 18, § 3343

Delaware’s mental health parity law (Del. Code Ann. tit. 18, § 3343) aligns with the federal Mental Health Parity and Addiction Equity Act (MHPAEA). Under this statute, Highmark BCBS Delaware must provide mental health and substance use disorder benefits. Including coverage for ADHD. That are no more restrictive than the benefits provided for comparable medical and surgical conditions. This means:

• Prior authorization requirements for ADHD medications may not be more burdensome than PA requirements for equivalent medical drugs
• Quantity limits on ADHD medications must align with quantity limits applied to comparable medical/surgical treatments
• Step therapy requirements must meet parity standards
• If Highmark denies a mental health claim more frequently than comparable medical claims, that may constitute a parity violation

If you believe a coverage denial violates § 3343, you may file a parity complaint with the Delaware Department of Insurance alongside your internal appeal.

Highmark BCBS Delaware ADHD Formulary (Express Scripts)

The following table reflects typical Express Scripts formulary tiers and prior authorization requirements for common ADHD medications under Highmark BCBS Delaware plans. Actual coverage, tier placement, and PA requirements vary by specific plan. Always verify your benefits by calling 1-800-241-5704 or logging into your Highmark member account.

Coverage and tier placement vary by specific Highmark BCBS Delaware plan. Verify your benefits before treatment. This information is for educational purposes only.

Delaware EPCS Requirements for ADHD Medications

Delaware’s Electronic Prescribing of Controlled Substances (EPCS) regulations (Delaware Board of Medical Licensure regulations, DE Admin Code Title 24, § 1700) require electronic prescriptions for Schedule II through Schedule V controlled substances. For ADHD treatment, this means:

Klarity Health providers are fully EPCS-compliant and can electronically prescribe Schedule II stimulants for eligible Delaware patients where clinically appropriate.

Prior Authorization for ADHD Medications: What to Expect

Prior authorization (PA) is a process where your prescriber must obtain approval from Highmark before a covered medication may be dispensed at the in-network pharmacy benefit rate. For ADHD medications under Highmark BCBS Delaware:

Generic stimulants (Tier 1. 2)

Most generic stimulants. Including generic amphetamine salts (Adderall generics) and generic methylphenidate (Ritalin/Concerta generics). Do not require prior authorization under typical Highmark commercial plans. Your provider can prescribe these directly, and coverage may apply without additional approval steps.

Brand stimulants (Tier 3. 4)

Brand-name stimulants such as Vyvanse (lisdexamfetamine), brand Adderall XR, and brand Concerta typically require both prior authorization and step therapy documentation. Step therapy means demonstrating that a generic stimulant was tried and found inadequate (e.g., due to side effects, lack of efficacy, or a medical exception). PA criteria commonly include:

• Documented ADHD diagnosis
• Evidence of a trial of at least one generic stimulant at an adequate dose and duration
• Clinical rationale for the brand-name medication specifically
• For pediatric patients: age-appropriate dosing and formulation documentation

Non-stimulants

Non-stimulant medications such as atomoxetine and viloxazine ER (Qelbree) may require prior authorization. Generic guanfacine ER and clonidine ER are typically available without PA at lower tiers. PA for non-stimulants generally requires documentation of a clinical reason for preferring a non-stimulant approach (e.g., stimulant intolerance, cardiovascular contraindication, substance use history).

Step Therapy Rights Under Delaware Law

Delaware law and MHPAEA parity requirements govern how Highmark may apply step therapy to mental health medications. If step therapy is required for a brand-name ADHD medication, you or your provider may be able to request a step therapy exception if:

• The required step drug is contraindicated for you
• You previously tried the required step drug and it was ineffective or caused adverse effects
• The required step drug would cause a clinically significant adverse reaction
• You are currently stable on the brand-name medication and switching would cause harm

Step therapy exception requests should be submitted through Express Scripts or directly through Highmark member services.

How to Start the Prior Authorization Process

1. Get an ADHD evaluation: A licensed provider must diagnose ADHD and document your clinical history.
2. Discuss medication options: Your provider will recommend the most clinically appropriate medication, considering generic vs. brand formulations and stimulant vs. non-stimulant options.
3. Provider submits PA request: If PA is required, your Klarity provider can submit the request directly to Express Scripts or Highmark, including all supporting clinical documentation.
4. PA review: Express Scripts or Highmark clinical reviewers assess the request, typically within 1. 3 business days (urgent requests may be expedited).
5. Approval or denial: If approved, your pharmacy may fill the prescription. If denied, you receive a written notice with the specific reason and your appeal rights.

How to Appeal a Highmark BCBS Delaware ADHD Coverage Denial

If Highmark or Express Scripts denies coverage for an ADHD medication, you have the right to appeal. Delaware and federal law provide a structured appeals process:

1. Internal appeal: File a formal appeal with Highmark within the timeframe specified in your denial letter. Include a letter from your provider explaining the medical necessity of the prescribed medication. Contact: 1-800-241-5704.
2. Expedited appeal (if urgent): If a delay in coverage would seriously jeopardize your health, request an expedited internal appeal. Highmark must respond within 72 hours.
3. Peer-to-peer (P2P) review: Your prescribing provider can request a P2P conversation with Highmark’s medical director before or during the appeal process. This often resolves denials.
4. Delaware Department of Insurance external review: If your internal appeal is denied, you may request an independent external review through the DE DOI. An independent review organization (IRO) examines the denial. Contact: 1-302-674-7300.
5. Parity complaint: If you believe Highmark is applying stricter criteria for ADHD coverage than for comparable medical/surgical conditions (violating Del. Code Ann. tit. 18, § 3343), file a parity complaint with the DE DOI alongside your external review request.
6. DOL EBSA (for ERISA employer plans): If your coverage is through an employer’s self-funded group health plan, the Department of Labor’s Employee Benefits Security Administration handles complaints. Contact: 1-866-444-3272.

Does Highmark BCBS Delaware Cover Telehealth ADHD Treatment?

Highmark Blue Cross Blue Shield Delaware covers telehealth services for mental health conditions, including ADHD evaluation and ongoing medication management. Delaware’s telehealth parity law requires that commercial insurers cover telehealth services at the same level as equivalent in-person services. This means your Highmark plan may cover telehealth ADHD visits with no additional barriers beyond those applied to in-person visits.

Schedule II controlled substances such as Adderall and Vyvanse can be prescribed via telemedicine for established patients by DEA-registered providers operating under applicable federal guidelines. Klarity Health providers maintain EPCS capability and comply with all Delaware and federal telehealth prescribing requirements.

How Klarity Health Works With Highmark BCBS Delaware

Klarity Health is a telehealth platform with over 2,000 licensed providers in our network, many of whom accept Highmark Blue Cross Blue Shield plans in Delaware. Our ADHD-specialized providers offer:

• Comprehensive ADHD evaluations and diagnosis
• Medication management for stimulant and non-stimulant ADHD medications
• Electronic prescribing (EPCS-compliant) for Schedule II stimulants
• Prior authorization support and clinical documentation
• Ongoing follow-up care and medication adjustments

Verify if your Highmark plan may cover ADHD treatment through Klarity Health.

Frequently Asked Questions

Does Highmark BCBS Delaware cover Adderall?

Generic amphetamine salts (the generic equivalent of Adderall) are typically covered at Tier 1. 2 under Highmark BCBS Delaware plans through Express Scripts, often without prior authorization. Brand-name Adderall XR may require PA and step therapy documentation. Coverage may vary by your specific plan.

Does Highmark BCBS Delaware cover Vyvanse?

Vyvanse (lisdexamfetamine) is typically a Tier 3. 4 medication under Highmark/ESI formularies, requiring prior authorization and step therapy (documentation of a prior generic stimulant trial). Your provider must submit a PA request with supporting clinical documentation. Coverage may vary by plan.

Do I need a paper prescription for ADHD medication in Delaware?

No. Delaware requires electronic prescribing (EPCS) for Schedule II controlled substances, which includes all stimulant ADHD medications (Adderall, Vyvanse, Ritalin, Concerta, and their generics). Paper prescriptions are not accepted unless a documented exemption applies. Non-stimulant ADHD medications are non-scheduled and do not require EPCS.

Can Highmark deny ADHD medication coverage under § 3343?

Del. Code Ann. tit. 18, § 3343 requires Highmark to provide ADHD coverage on terms no more restrictive than comparable medical/surgical coverage. If a denial appears more restrictive than how Highmark handles equivalent medical conditions, you may have grounds for a parity complaint with the DE Department of Insurance (1-302-674-7300).

How long does prior authorization take for ADHD medication?

Standard PA reviews through Express Scripts typically take 1. 3 business days. Urgent/expedited PA requests. When a delay would seriously jeopardize health. Must be decided within 24. 72 hours. Your Klarity provider can assist with PA submission to help minimize delays.

Is telehealth ADHD treatment covered by Highmark BCBS Delaware?

Highmark Blue Cross Blue Shield Delaware covers telehealth mental health services, including ADHD evaluation and medication management, in line with Delaware’s telehealth parity requirements. Coverage may vary by plan. Klarity Health providers accept many Highmark plans and offer full telehealth ADHD services.

Key Contacts

• Highmark BCBS Delaware member services: 1-800-241-5704
• Express Scripts pharmacy: 1-800-792-9558
• Delaware Department of Insurance: 1-302-674-7300
• DOL Employee Benefits Security Administration (ERISA plans): 1-866-444-3272

Disclaimer: Coverage for ADHD treatment, medications, and telehealth services varies by Highmark Blue Cross Blue Shield Delaware plan, plan year, and individual eligibility. The information on this page is for educational purposes only and does not constitute insurance advice. Verify your specific benefits by contacting Highmark member services at 1-800-241-5704 or reviewing your Summary of Benefits and Coverage (SBC). Klarity Health cannot guarantee coverage or reimbursement for any specific service.